The Lancet Infectious Diseases

The Lancet Infectious Diseases, published monthly, provides infectious diseases specialists something truly rare and valuable—definitive coverage of all aspects of infectious diseases from around the world—in a single, highly readable source. Every month, The Lancet Infectious Diseases reviews the most recent research, highlighting those advances with the greatest and most immediate impact. Our global reporting capabilities ensure that The Lancet Infectious Diseases provides the most important and current international news from this vast medical specialty. 

For our advertisers, this high profile journal provides an excellent platform from which to advertise your products and services relevant to the infectious disease specialist. We are confident that The Lancet Infectious Diseases is the first place infectious disease specialists look when investigating well-respected opinion, news and reviews, or the latest in important clinical trials. Combining print advertising with electronic advertising opportunities on The Lancet Infectious Diseases web site, we give you, our advertisers, a first-class media solution, which rivals anything available in medical publishing. The Lancet Infectious Diseases is your best opportunity to reach the infectious disease professional.

Editor in Chief: John McConnel
2023
The Lancet Infectious Diseases
Global Print Circulation
10,000
Avg. Global Monthly Visits
292,563
Avg. Global Monthly Unique Visitors
244,519
Avg. Global Monthly Page Views
399,652
Circulation updated on November 9, 2022. Circulation maintained at 10,000 from controlled subscribers and/or the inclusion of sponsored distribution. For additional information please contact your Elsevier Sales Representative eTOC Metrics: 6 Month Average of eTOC sends - Nov 2022 to April 2023

Contacts

Display Advertising

Recruitment Advertising

Looking for more information?

If you would like to be contacted by one of our advertising experts, please complete our Request Contact form and we will get right back to you.